Biorce: Difference between revisions
Created company page — Spain |
Added valuation: ~€200M implied ($52.5M Series A, 2025) |
||
| Line 11: | Line 11: | ||
== Funding == | == Funding == | ||
'''Valuation:''' ~€200M implied ($52.5M Series A, 2025) | |||
€43.8M Series A (2025) | €43.8M Series A (2025) | ||
Revision as of 07:42, 14 April 2026
What They Do
AI-driven clinical trials platform accelerating drug development. Uses machine learning to optimize trial design, patient recruitment, and protocol optimization.
Funding
Valuation: ~€200M implied ($52.5M Series A, 2025) €43.8M Series A (2025)